Clinical and functional status over the first three months of treatment: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study

被引:0
|
作者
Edgell, ET [1 ]
Haro, JM [1 ]
Frewer, P [1 ]
Wright, P [1 ]
机构
[1] Eli Lilly & Co Ltd, Lilly Res Ctr, Surrey, England
关键词
D O I
10.1016/S0920-9964(03)80456-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:282 / 282
页数:1
相关论文
共 50 条
  • [21] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [22] Tolerability of outpatient antipsychotic treatment: 6-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Lambert, K
    Jones, P
    Novick, D
    Lorenzo, M
    Tzivelekis, S
    Ratcliffe, M
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 188 - 188
  • [23] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Edgell, ET
    Kennedy, L
    Lepine, JP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
  • [24] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [25] Change in clinical status and quality of life of schizophrenic patients in Germany: Six month results from the schizophrenia outpatient health outcomes (SOHO) study
    Naber, D
    Krausz, M
    Dittmann, RW
    Mahl, C
    Langer, F
    Wagner, T
    Linder, P
    Novick, D
    Czekalla, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S326 - S327
  • [26] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
  • [27] Sexual dysfunction associated with antipsychotic treatment for schizophrenia: Results from the first 12 months of the Intercontinental Schizophrenia Outpatients Health Outcomes (IC-SOHO) study
    Kim, CY
    Kim, CE
    Hsiao, CC
    Ree, SC
    Singh, S
    Hodge, A
    Lowry, AJ
    Lee, PP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S273 - S273
  • [28] Predictors of antipsychotic treatment continuation in the outpatient setting: 12-month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Ratcliffe, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S233 - S234
  • [29] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Bushe, C
    Murray, D
    Texeira, JM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
  • [30] ECONOMIC CONSEQUENCES OF MEDICATION NONADHERENCE IN THE TREATMENT OF SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SOHO (SCHIZOPHRENIA OUTPATIENT HEALTH OUTCOMES) STUDY
    Hong, J.
    Novick, D.
    Haro, J. M.
    Knapp, M.
    EUROPEAN PSYCHIATRY, 2010, 25